THE RISK OF LATE BREAST CANCER SCREENING VERSUS AXILLARY LYMPHADENOPATHY ASSOCIATED WITH COVID-19 VACCINATION (Atena Editora)

Arquivos associados:
THE RISK.pdf180,33 kBAdobe PDF/bitstream/capes/701822/1/THE RISK.pdfDownload
Título: 
Autor(es) e Colaborador(es): 
recommendations, The coronavirus ANA CAROLINA MORAES GOMES DE SOUZAdisease 2019 (COVID-19) pandemic has significantly impacted morbidity and mortality worldwide. Unilateral axillary lymphadenopathy induced by the COVID-19 vaccine is particularly relevant in women with breast cancer, with a predilection for metastasis to the axillary lymph nodes. Clinicians, radiologists, and patients may be concerned about COVID-19 vaccine-induced unilateral axillary lymphadenopathy because it may be a sign of breast cancer metastasis, leading to a diagnostic conundrum over whether to recommend a biopsy or short-term follow-up. This literature review aims to assess the best available evidence of axillary lymphadenopathy after COVID-19 vaccination. Recognizing COVID-19 vaccine-induced unilateral axillary lymphadenopathy as a potential differential diagnosis and making efforts to investigate the patient's vaccination history are crucial to avoid overestimating the burden of axillary disease and making appropriate therapeutic .
NOSE, ANDRE LUIS YAMAMOTO
LOPES, PATRICK DE ABREU CUNHA
Data: 
18-Abr-2022
Tipo: 
Palavras-chave: 
Aparece nas coleções:Livros digitais